Apellis Pharmaceuticals, Inc. (APLS)

Apellis Pharmaceuticals Employees

As of December 31, 2025, Apellis Pharmaceuticals had 739 total employees, including 733 full-time and 6 part-time employees. The number of employees increased by 29 or 4.08% compared to the previous year.

• Employees: 739
• Change (1Y): 29
• Growth (1Y): 4.08%
• Revenue / Employee: $1,495,643
• Profits / Employee: $180,337
• Market Cap: 5.25B

Employees History

Date	Employees	Change (1Y)	Growth (1Y)	Full-Time	Part-Time
Dec 31, 2025	739	29	4.08%	733	6
Dec 31, 2024	710	4	0.57%	705	5
Dec 31, 2023	706	-61	-7.95%	702	4
Dec 31, 2022	767	291	61.13%	767	0
Dec 31, 2021	476	102	27.27%	476	0
Sep 30, 2021	486	136	38.86%	486	0
Jun 30, 2021	445	148	49.83%	445	0
Mar 31, 2021	391	125	46.99%	391	0

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Employee data is provided by S&P Global Market Intelligence and updates every three months after the filing of each quarterly report.

Update frequency:

Quarterly

Last checked:

May 15, 2026

Data Sources Report a data error